3,4-Dideoxyglucosone-3-ene as a mediator of peritoneal demesothelization

Nephrology Dialysis Transplantation

Volumn 23, Issue 10, 2008, Pages 3307-3315

  Santamaría, Beatriz ^a   Ucero, Alvaro C ^a   Reyero, Ana ^a   Selgas, Rafael ^b   Ruiz Ortega, Marta ^a   Catalán, Marina ^a   Egido, Jesús ^a   Ortiz, Alberto ^a  

^a Hospital UniversitarioFundación Jiménez Díaz   (Spain)

^b HOSPITAL UNIVERSITARIO LA PAZ   (Spain)

Author keywords

Apoptosis; Bax; Caspases; Glucose degradation products; Mesothelium peritoneal dialysis

Indexed keywords

3,4 DIDEOXYGLUCOSONE 3 ENE; CASPASE; CASPASE INHIBITOR; DNA; GLUCOSE; PROTEIN BAX; UNCLASSIFIED DRUG;

APOPTOSIS; ARTICLE; CELL CULTURE; CELL VIABILITY; CONFOCAL MICROSCOPY; CONTROLLED STUDY; DRUG INHIBITION; ENZYME ACTIVATION; HUMAN; HUMAN CELL; MESOTHELIUM CELL; MITOCHONDRIAL MEMBRANE; OLIGOMERIZATION; PERITONEAL CAVITY; PERITONEAL DIALYSIS; PRIORITY JOURNAL; PROTEIN DEGRADATION;

AGED; APOPTOSIS; BCL-2-ASSOCIATED X PROTEIN; CASPASES; CELL DEATH; CELLS, CULTURED; DIALYSIS SOLUTIONS; EPITHELIUM; FEMALE; GLUCOSE; HUMANS; KIDNEY FAILURE, CHRONIC; MALE; MIDDLE AGED; PERITONEAL DIALYSIS, CONTINUOUS AMBULATORY; PERITONEUM; PYRONES;

EID: 52449126916     PISSN: 09310509     EISSN: 14602385     Source Type: Journal    
DOI: 10.1093/ndt/gfn273     Document Type: Article

References (35)

1. Catalan MP, Subira D, Reyero A et al. Regulation of apoptosis by lethal cytokines in human mesothelial cells. Kidney Int 2003; 64: 321-330
2. Yanez-Mo M, Lara-Pezzi E, Selgas R et al. Peritoneal dialysis and epithelial-to-mesenchymal transition of mesothelial cells. N Engl J Med 2003; 348: 403-413
3. Ortiz A. Nephrology forum: apoptotic regulatory proteins in renal injury. Kidney Int 2000; 58: 467-485
4. Carracedo J, Ramirez R, Soriano S, Martin-Malo A, Rodriguez M, Aljama P. Caspase-3-dependent pathway mediates apoptosis of human mononuclear cells induced by cellulosic haemodialysis membranes. Nephrol Dial Transplant 2002; 17: 1971-1977
5. Zheng Z, Ye R, Yu X, Bergstrom J, Lindholm B. Peritoneal dialysis solutions disturb the balance of apoptosis and proliferation of peritoneal cells in chronic dialysis model. Adv Perit Dial 2001; 17: 53-57
6. Gotloib L, Wajsbrot V, Shostak A, Khrizman V. Repopulation of the mesothelial monolayer during long-term experimental peritoneal dialysis. Contrib Nephrol 2006; 150: 54-61
7. Baumgartner-Parzer SM, Wagner L, Pettermann M, Grillari J, Gessl A, Waldhausl W. High-glucose-triggered apoptosis in cultured endothelial cells. Diabetes 1995; 44: 1323-1327
8. Moley KH, Chi MM, Knudson CM, Korsmeyer SJ, Mueckler MM. Hyperglycemia induces apoptosis in pre-implantation embryos through cell death effector pathways. Nat Med 1998; 4: 1421-1424
9. Erixon M, Linden T, Kjellstrand P et al. PD fluids contain high concentrations of cytotoxic GDPs directly after sterilization. Perit Dial Int 2004; 24: 392-398
10. Wieslander A, Forsback G, Svensson E, Linden T. Cytotoxicity, pH, and glucose degradation products in four different brands of PD fluid. Adv Perit Dial 1996; 12: 57-60
11. Tauer A, Zhang X, Schaub TP et al. Formation of advanced glycation end products during CAPD. Am J Kidney Dis 2003; 41: S57-S60
12. Catalan MP, Santamaria B, Reyero A, Ortiz A, Egido J, Ortiz A. 3,4-di-deoxyglucosone-3-ene promotes leukocyte apoptosis. Kidney Int 2005; 68: 1303-1311
13. Santamaria B, Sanz A, Justo P et al. Peritoneal defence-lessons learned which apply to diabetes complications. Nephrol Dial Transplant 2006; 21 Suppl 2: ii12-ii15
14. Justo P, Sanz AB, Egido J, Ortiz A. 3,4-Dideoxyglucosone-3-ene induces apoptosis in renal tubular epithelial cells. Diabetes 2005; 54: 2424-2429
15. Williams JD, Topley N, Craig KJ et al. The Euro-Balance Trial: the effect of a new biocompatible peritoneal dialysis fluid (balance) on the peritoneal membrane. Kidney Int 2004; 66: 408-418
16. Diaz C, Selgas R, Castro MA et al. Ex vivo proliferation of mesothelial cells directly obtained from peritoneal effluent: its relationship with peritoneal antecedents and functional parameters. Adv Perit Dial 1998; 14: 19-24
17. Nilsson-Thorell CB, Muscalu N, Andren AH, Kjellstrand PT, Wieslander AP. Heat sterilization of fluids for peritoneal dialysis gives rise to aldehydes. Perit Dial Int 1993; 13: 208-213
18. Linden T, Forsback G, Deppisch R, Henle T, Wieslander A. 3-Deoxyglucosone, a promoter of advanced glycation end products in fluids for peritoneal dialysis. Perit Dial Int 1998; 18: 290-293
19. Linden T, Cohen A, Deppisch R, Kjellstrand P, Wieslander A. 3,4-Dideoxyglucosone-3-ene (3,4-DGE): a cytotoxic glucose degradation product in fluids for peritoneal dialysis. Kidney Int 2002; 62: 697-703
20. Catalan MP, Reyero A, Egido J, Ortiz A. Acceleration of neutrophil apoptosis by glucose-containing peritoneal dialysis solutions: role of caspases. J Am Soc Nephrol 2001; 12: 2442-2449
21. Justo P, Lorz C, Sanz A, Egido J, Ortiz A. Intracellular mechanisms of cyclosporin A-induced tubular cell apoptosis. J Am Soc Nephrol 2003; 14: 3072-3080
22. Sawada M, Sun W, Hayes P, Leskov K, Boothman DA, Matsuyama S. Ku70 suppresses the apoptotic translocation of Bax to mitochondria. Nat Cell Biol 2003; 5: 320-329
23. Guillermet J, Saint-Laurent N, Rochaix P et al. Somatostatin receptor subtype 2 sensitizes human pancreatic cancer cells to death ligand-induced apoptosis. Proc Natl Acad Sci U S A 2003; 100: 155-160
24. Morgan LW, Wieslander A, Davies M et al. Glucose degradation products (GDP) retard remesothelialization independently of D-glucose concentration. Kidney Int 2003; 64: 1854-1866
25. Chen JY, Chi CW, Chen HL, Wan CP, Yang WC, Yang AH. TNF-alpha renders human peritoneal mesothelial cells sensitive to anti-Fas antibody-induced apoptosis. Nephrol Dial Transplant 2003; 18: 1741-1747
26. Di PN, Sacchi G. Atlas of peritoneal histology. Perit Dial Int 2000; 20 Suppl 3: S5-96
27. Amore A, Cappelli G, Cirina P et al. Glucose degradation products increase apoptosis of human mesothelial cells. Nephrol Dial Transplant 2003; 18: 677-688
28. Boulanger E, Wautier MP, Gane P, Mariette C, Devuyst O, Wautier JL. The triggering of human peritoneal mesothelial cell apoptosis and oncosis by glucose and glycoxydation products. Nephrol Dial Transplant 2004; 19: 2208-2216
29. Welten AG, Schalkwijk CG, ter Wee PM, Meijer S, Van Den BJ, Beelen RJ. Single exposure of mesothelial cells to glucose degradation products (GDPs) yields early advanced glycation end-products (AGEs) and a proinflammatory response. Perit Dial Int 2003; 23: 213-221
30. Wieslander AP, Andren AH, Nilsson-Thorell C, Muscalu N, Kjellstrand PT, Rippe B. Are aldehydes in heat-sterilized peritoneal dialysis fluids toxic in vitro? Perit Dial Int 1995; 15: 348-352
31. Schalkwijk CG, Posthuma N, ten Brink HJ, ter Wee PM, Teerlink T. Induction of 1,2-dicarbonyl compounds, intermediates in the formation of advanced glycation end-products, during heat-sterilization of glucose-based peritoneal dialysis fluids. Perit Dial Int 1999; 19: 325-333
32. Ortiz A, Wieslander A, Linden T et al. 3,4-DGE is important for side effects in peritoneal dialysis what about its role in diabetes. Curr Med Chem 2006; 13: 2695-2702
33. Tsukushi S, Kajita M, Nakamura S, Niwa T. Gas chromatographic-mass spectrometric determination of erythrocyte 3-deoxyglucosone in diabetic patients. J Chromatogr B Analyt Technol Biomed Life Sci 2002; 776: 133-137
34. Catalan MP, Esteban J, Subira D, Egido J, Ortiz A. Inhibition of caspases improves bacterial clearance in experimental peritonitis. Perit Dial Int 2003; 23: 123-126
35. Hotchkiss RS, Chang KC, Swanson PE et al. Caspase inhibitors improve survival in sepsis: a critical role of the lymphocyte. Nat Immunol 2000; 1: 496-501